393 related articles for article (PubMed ID: 10613094)
1. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
Aanonsen NO
Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
[TBL] [Abstract][Full Text] [Related]
2. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
Kollins SH
J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
[TBL] [Abstract][Full Text] [Related]
3. [Central stimulants in adults with AD/HD. Can they be abused?].
Lie N
Tidsskr Nor Laegeforen; 1998 Nov; 118(27):4227-9. PubMed ID: 9857807
[TBL] [Abstract][Full Text] [Related]
4. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate: abuse and addiction.
Prescrire Int; 2012 Oct; 21(131):241. PubMed ID: 23189380
[No Abstract] [Full Text] [Related]
6. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
[TBL] [Abstract][Full Text] [Related]
7. [Central stimulants in adults with AD/HD. Do they help?].
Lie N
Tidsskr Nor Laegeforen; 1998 Nov; 118(27):4223-7. PubMed ID: 9857806
[TBL] [Abstract][Full Text] [Related]
8. Impact of ADHD and its treatment on substance abuse in adults.
Wilens TE
J Clin Psychiatry; 2004; 65 Suppl 3():38-45. PubMed ID: 15046534
[TBL] [Abstract][Full Text] [Related]
9. Methylphenidate and dextroamphetamine-induced peripheral vasculopathy.
Syed RH; Moore TL
J Clin Rheumatol; 2008 Feb; 14(1):30-3. PubMed ID: 18431096
[TBL] [Abstract][Full Text] [Related]
10. [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].
Pelz R; Banaschewski T; Becker K
Klin Padiatr; 2008; 220(2):93-100. PubMed ID: 18157763
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents.
Williams RJ; Goodale LA; Shay-Fiddler MA; Gloster SP; Chang SY
Am J Addict; 2004; 13(4):381-9. PubMed ID: 15370936
[TBL] [Abstract][Full Text] [Related]
12. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
13. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
Kollins SH
J Atten Disord; 2008 Sep; 12(2):115-25. PubMed ID: 18192623
[TBL] [Abstract][Full Text] [Related]
14. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
Faraone SV; Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
[TBL] [Abstract][Full Text] [Related]
15. [Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
Durst R; Rebaudengo-Rosca P
Harefuah; 1997 May; 132(9):618-22, 680. PubMed ID: 9225572
[TBL] [Abstract][Full Text] [Related]
16. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
17. The effect of methylphenidate on response inhibition and the event-related potential of children with attention deficit/hyperactivity disorder.
Broyd SJ; Johnstone SJ; Barry RJ; Clarke AR; McCarthy R; Selikowitz M; Lawrence CA
Int J Psychophysiol; 2005 Oct; 58(1):47-58. PubMed ID: 15925419
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
[No Abstract] [Full Text] [Related]
19. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
[TBL] [Abstract][Full Text] [Related]
20. [Central nervous system stimulants in AD/HD in adults].
Aanonsen NO; Lensing MB; Mathiesen T
Tidsskr Nor Laegeforen; 1999 Jan; 119(1):82-3. PubMed ID: 10025211
[No Abstract] [Full Text] [Related]
[Next] [New Search]
